Treatment
Medication clinical trials
We’re tracking 7,451 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07665190RecruitingPhase 2
New drug combination before surgery for advanced throat cancer
This trial tests a new combination of a targeted therapy (EGFR-ADC) and an immunotherapy drug before surgery to shrink and control locally advanced throat cancer. It may help make surgery more effective and reduce the chance of recurrence.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07224113Recruiting
Reducing ultra-processed foods in teens with IBD
This study looks at whether a simple educational program can help teens with IBD eat less ultra-processed foods (like fast food and sugary snacks). Participants will learn about healthier food choices during their regular infusion visits.
Hartford, ConnecticutAges 10–21 - NCT07543692Recruiting
Ultrasound-guided injection therapy for spine pain
This study tests whether using ultrasound imaging to guide a special injection treatment (pharmacopuncture) is safe and effective for people with spine-related neck or lower back pain that radiates into the arms or legs. The treatment is already being offered as routine care, and this study tracks how well it works.
Daejeon, DaejeonAges 19–69 - NCT03023371Recruiting
National registry for IgG4-related disease in China
This study is a registry that collects information about people diagnosed with IgG4-related disease (a specific immune-related condition). It helps doctors better understand the condition and how it looks and behaves in real life.
Beijing, Beijing MunicipalityAges Any age - NCT07704177RecruitingPhase 2
A study of trastuzumab rezetecan plus two other drugs for advanced bile duct cancer
This trial tests a combination of three drugs (trastuzumab rezetecan, adebrelimab, and lenvatinib) for people with advanced bile duct or gallbladder cancer that has HER2 protein on its cells. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18–80 - NCT07287423Recruiting
A study of a new pacemaker system for heart rhythm problems
This trial tests a new pacemaker system for people who need a pacemaker for a slow or irregular heartbeat. It aims to see if the system is safe and works well.
PragueAges 18 years+ - NCT07704424Recruiting
Testing a heart pump for severe right heart failure
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
Hefei, AnhuiAges 18 years+ - NCT07704138Recruiting
Testing process-based therapy for depression and anxiety
This trial tests a type of talking therapy called process-based therapy to see how well it works in everyday care. It focuses on treating depression or anxiety and helps therapists learn how to make better treatment decisions.
Frankfurt am Main, HesseAges 18–65 - NCT05810480Recruiting
Predicting steroid-dependent liver injury with blood test
This study looks at whether a specific blood marker can predict which patients with liver inflammation will need long-term steroid treatment. It may help doctors decide the best treatment for you if you have unexplained liver injury.
AachenAges Any age - NCT07700940RecruitingPhase 4
Empagliflozin for kidney function in lupus nephritis
This trial tests if empagliflozin, a medicine used for diabetes, can help protect kidney function in people with active lupus nephritis. You may be eligible if you have a lupus kidney flare with significant protein in your urine.
Banī SuwayfAges 18–65 - NCT07705178Recruiting
MRI study of heart and lung health after childhood cancer
This study uses MRI scans to look at the heart and lungs of childhood cancer survivors to see if chemotherapy caused any long-term changes. It may help doctors better understand and manage late effects after treatment for leukemia or lymphoma.
ErlangenAges 3 years+ - NCT07258563Recruiting
Can a special diet prevent taste changes from chemo?
This study looks at whether a special diet can help prevent taste changes during chemotherapy. It is for people with certain cancers who are about to start treatment.
AmsterdamAges 18–70 - NCT07328347Recruiting
Improving dental care for head and neck cancer
This study looks at how to make dental care better for people with head and neck tumors. Dentists in Germany will also take part to share their views.
GöttingenAges 18 years+ - NCT07010497RecruitingPhase 2
Study of a three-drug combo for advanced liver cancer
This trial tests a new combination of three drugs (Irpagratinib, Atezolizumab, and Bevacizumab) for people with advanced liver cancer that cannot be removed by surgery. It aims to see if this combination is safe and effective.
SeoulAges 19 years+ - NCT07104604RecruitingPhase 2
New combo before surgery for low rectal cancer
This trial tests a new combination of treatments (radiation, immunotherapy, and two chemotherapy drugs) given before surgery for people with a specific type of locally advanced rectal cancer that is close to the anus. The goal is to see if this approach is safe and effective.
Shantou, GuangdongAges 18–75 - NCT02971358Recruiting
Surgery for very high-risk or limited-spread prostate cancer
This trial looks at how safe and how well early prostate surgery works for men with newly diagnosed very high-risk prostate cancer or a limited number of metastases (cancer spread). It may help some people live longer and control the cancer, but eligibility is very specific.
ViennaAges 18–75 - NCT02986581Recruiting
Study of hospital rapid response teams for general ward patients
This study looks at how the hospital’s rapid response system helps when patients on regular hospital wards start to worsen. It is meant to improve how quickly staff recognize and respond to serious changes in condition.
Seongnam-siAges 15 years+ - NCT02989025RecruitingPhase 2
Progesterone for some preterm preeclampsia pregnancies
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
Jackson, MississippiAges 18–45 - NCT03001180Recruiting
Study blood and tissue markers in vascular anomalies
This study collects extra blood (and sometimes tissue during procedures) to look for markers that can help doctors better understand vascular anomalies. It may not be a treatment, but it can improve future care by finding patterns linked to the condition.
Boston, MassachusettsAges 1 day+ - NCT03014687RecruitingPhase 4
Preventing sinus symptoms after pituitary surgery with antibiotics
This trial studies whether taking antibiotic medicine by mouth after endoscopic pituitary surgery can reduce post-surgery sinus and nasal symptoms. It may help people recover more comfortably and improve specific nasal outcome scores.
Phoenix, ArizonaAges 18–84 - NCT03042988Recruiting
Heat stress test in people with low nerve control and high blood pressure
This study checks how your body’s blood pressure and stress responses change after being exposed to heat overnight. It’s meant for people with autonomic failure (like certain Parkinson-related or nerve-function conditions) who also have high blood pressure while lying down, which may help researchers understand safer ways to manage it.
Nashville, TennesseeAges 18–80 - NCT03097952Recruiting
Study of people with long-term hepatitis B in real life
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
Changzhou, JiangsuAges Any age - NCT03101813Recruiting
Share DIPG/DMG tumor information for an international registry
This trial builds an international registry (a secure collection of patient records) for people who have been diagnosed with DIPG/DMG, including children and adults. Sharing information can help researchers better understand these tumors and plan future studies.
Cincinnati, OhioAges Any age - NCT03117010Recruiting
Study of adults with suspected or confirmed HLH
This study follows adults who have findings that suggest HLH, a serious immune problem. It may help doctors better understand the condition by tracking patients over time and comparing symptoms and test results.
SeoulAges 18–80
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,451 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.